AAAAAA

   
Results: 1-9 |
Results: 9
Serum-free recombinant production of adenovirus using a hollow fiber capillary system
Authors: Gardner, TA Ko, SC Yang, L Cadwell, JJS Chung, LWK Kao, C
Citation: Ta. Gardner et al., Serum-free recombinant production of adenovirus using a hollow fiber capillary system, BIOTECHNIQU, 30(2), 2001, pp. 422
Drug-resistant human bladder-cancer cells are more sensitive to adenovirus-mediated wild-type p53 gene therapy compared to drug-sensitive cells
Authors: Shirakawa, T Sasaki, R Gardner, TA Kao, CH Zhang, ZJ Sugimura, K Matsuo, M Kamidono, S Gotoh, A
Citation: T. Shirakawa et al., Drug-resistant human bladder-cancer cells are more sensitive to adenovirus-mediated wild-type p53 gene therapy compared to drug-sensitive cells, INT J CANC, 94(2), 2001, pp. 282-289
A conditional replication-competent adenoviral vector, Ad-OC-E1a, to cotarget prostate cancer and bone stroma in an experimental model of androgen-independent prostate cancer bone metastasis
Authors: Matsubara, S Wada, Y Gardner, TA Egawa, M Park, MS Hsieh, CL Zhau, HE Kao, C Kamidono, S Gillenwater, JY Chung, LWK
Citation: S. Matsubara et al., A conditional replication-competent adenoviral vector, Ad-OC-E1a, to cotarget prostate cancer and bone stroma in an experimental model of androgen-independent prostate cancer bone metastasis, CANCER RES, 61(16), 2001, pp. 6012-6019
p53 Adenoviral vector (Ad-CMV-p53) induced prostatic growth inhibition of primary cultures of human prostate and an experimental rat model
Authors: Shirakawa, T Gotoh, A Gardner, TA Kao, CH Zhang, ZJ Matsubara, S Wada, Y Hinata, N Fujisawa, M Hanioka, K Matsuo, M Kamidono, S
Citation: T. Shirakawa et al., p53 Adenoviral vector (Ad-CMV-p53) induced prostatic growth inhibition of primary cultures of human prostate and an experimental rat model, J GENE MED, 2(6), 2000, pp. 426-432
Tissue-specific promoters in gene therapy for the treatment of prostate cancer
Authors: Shirakawa, T Gotoh, A Wada, Y Kamidono, S Ko, SC Kao, CH Gardner, TA Chung, LWK
Citation: T. Shirakawa et al., Tissue-specific promoters in gene therapy for the treatment of prostate cancer, MOL UROL, 4(2), 2000, pp. 73-82
Osteocalcin-directed gene therapy for prostate-cancer bone metastasis
Authors: Koeneman, KS Kao, CH Ko, SC Yang, L Wada, Y Kallmes, DF Gillenwater, JY Zhau, HE Chung, LWK Gardner, TA
Citation: Ks. Koeneman et al., Osteocalcin-directed gene therapy for prostate-cancer bone metastasis, WORLD J URO, 18(2), 2000, pp. 102-110
Surgical and postoperative factors affecting length of hospital stay afterradical prostatectomy
Authors: Gardner, TA Bissonette, EA Petroni, GR McClain, R Sokoloff, MH Theodorescu, D
Citation: Ta. Gardner et al., Surgical and postoperative factors affecting length of hospital stay afterradical prostatectomy, CANCER, 89(2), 2000, pp. 424-430
Calcium carbonate binder therapy: Impact on serum lipids in hemodialysis patients
Authors: Gardner, TA Yates, LA Soffer, O Gropper, SS
Citation: Ta. Gardner et al., Calcium carbonate binder therapy: Impact on serum lipids in hemodialysis patients, DIALYSIS T, 28(11), 1999, pp. 641
Cytotoxicity of adenoviral-mediated cytosine deaminase plus 5-fluorocytosine gene therapy is superior to thymidine kinase plus acyclovir in a human renal cell carcinoma model
Authors: Shirakawa, T Gardner, TA Ko, SC Bander, N Woo, S Gotoh, A Kamidono, S Chung, LWK Kao, C
Citation: T. Shirakawa et al., Cytotoxicity of adenoviral-mediated cytosine deaminase plus 5-fluorocytosine gene therapy is superior to thymidine kinase plus acyclovir in a human renal cell carcinoma model, J UROL, 162(3), 1999, pp. 949-954
Risultati: 1-9 |